![](https://investorshub.advfn.com/uicon/138434.png?cb=1464725830)
Thursday, March 30, 2023 7:01:42 PM
The companies he gave as examples were Atea Pharmaceuticals, Appili Therapeutics, CytoDyn, and Humanigen, etc.
Thanks. Interesting how he’s blaming the fda. Plenty folks here had both sides of that coin. They said fda is corrupt while saying also the fda was working with rvv on steps toward approval
I would think if they couldn’t get it done as MF stated then why waste time and money and simply partner or license to a BP?? If they don’t then all hope is lost and the drug isn’t what it seems
Sure this is now option 4 in the PR so maybe one day folks will wake up to a pps above 1.00 with news of some arrangement
Gltu
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM